US 12269889
Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12269889 (Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39541, A61K39/3955